Skip to main content
TipRanks
Go Ultimate75% OFF

GC Biopharma Corp. (006280) Revenue

GC Biopharma Corp. Revenue

GC Biopharma Corp. had a revenue of 421.20B in the quarter ending Jun 30, 2026, with -3.28%. This bring the company's revenue in the last twelve months to 1.96T, Decreased 3.87%. In the fiscal year ending Dec 31, 2025, GC Biopharma Corp. had annual revenue of 1.99T with 18.54% growth.

Revenue (ttm)
1.96T
Revenue Growth
-2.99%
P/S Ratio
0.76
Revenue/Employee
KRW 846,992,384
Employees
2,351
Market Cap
KRW 1.51T

Revenue Chart

GC Biopharma Corp. Revenue - Annual

0500B1T1.5T2T2.5T1.29T1.33T1.37T1.50T1.54T1.71T1.63T1.68T1.99T201720182019202020212022202320242025
Revenue History
Download to Excel
KR:006280 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20251.99T311.39B18.54%
Dec 31, 20241.68T53.25B3.27%
Dec 31, 20231.63T-84.67B-4.95%
Dec 31, 20221.71T173.49B11.28%
Dec 31, 20211.54T33.71B2.24%
Dec 31, 20201.50T134.41B9.81%
Dec 31, 20191.37T34.83B2.61%
Dec 31, 20181.33T46.96B3.65%
Dec 31, 20171.29T――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
KR:0062801.96T
KR:009420161.76B
KR:068760536.40B
KR:0696201.68T
KR:1857501.78T
KR:195940―